Check out our vacancies! We look for people who are inspired by our mission to change the lives of patients. Are you up for the challenge to become a ProQRian?
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments.
If you would like to join our team at ProQR but you can't find the right job opening at this moment, you're always welcome to send us an open application by filling out the application form.
Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.
This website contains forward-looking statements about potential therapeutic uses and effects of ProQR Therapeutics’ products, including but not limited to our technologies.
Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
ProQR invented an entirely new way to treat genetic diseases. Axiomer enables RNA base editing by recruiting ADAR so your own body can treat disease. Learn more here.
